Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma

BACKGROUND: Despite its toxicity, cisplatin every 3 weeks (q3w) is the standard potentiation of chemo-radiotherapy for head and neck squamous cell carcinoma. This study aimed to determine whether weekly cisplatin (q1w) could be a safe and effective alternative. PATIENTS AND METHODS: Two hundred and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Des Devel Ther
Autors principals: Fayette, Jérôme, Molin, Yann, Lavergne, Emilie, Montbarbon, Xavier, Racadot, Séverine, Poupart, Marc, Ramade, Antoine, Zrounba, Philippe, Ceruse, Philippe, Pommier, Pascal
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4664534/
https://ncbi.nlm.nih.gov/pubmed/26648696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S81488
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars